Table 3.
Overall Disagreement |
CLL/SLL Disagreement |
HL Disagreement |
NHL Disagreement |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N (%) | p-value | N (%) | p-value | N (%) | p-value | N (%) | p-value | ||||
|
|
|
|
||||||||
Age | 0.001 | Age | 0.014 | Age | 0.65 | Age | 0.004 | ||||
≤ 60 | 609 (30%) | ≤ 60 | 103 (19%) | ≤ 60 | 103 (34%) | ≤ 60 | 403 (32%) | ||||
> 60 | 660 (39%) | > 60 | 172 (32%) | > 60 | 24 (29%) | > 60 | 464 (42%) | ||||
Gender | 0.37 | Gender | 0.78 | Gender | 0.11 | Gender | 0.37 | ||||
Female | 529 (33%) | Female | 93 (28%) | Female | 55 (26%) | Female | 381 (36%) | ||||
Male | 740 (36%) | Male | 182 (26%) | Male | 72 (39%) | Male | 486 (39%) | ||||
Education | 0.48 | Education | 0.58 | Education | 0.85 | Education | 0.61 | ||||
High school or less | 208 (36%) | High school or less | 54 (26%) | High school or less | 13 (23%) | High school or less | 141 (41%) | ||||
Some college | 215 (35%) | Some college | 54 (30%) | Some college | 15 (27%) | Some college | 146 (38%) | ||||
College graduate | 321 (32%) | College graduate | 91 (22%) | College graduate | 32 (31%) | College graduate | 198 (36%) | ||||
Subtype | 0.006 | Rai Stage | 0.27 | IPS | 0.027 | IPI | <0.0001 | ||||
CLL/SLL | 275 (27%) | 0 | 123 (24%) | 1 | 17 (12%) | 0-1 | 221 (29%) | ||||
HL | 127 (33%) | 1 | 108 (29%) | 2 | 746 (26%) | 2 | 188 (44%) | ||||
NHL | 867 (37%) | 2-4 | 26 (39%) | 3 | 37 (38%) | 3 | 137 (48%) | ||||
4-6 | 27 (52%) | 4-5 | 80 (61%) | ||||||||
Aggressiveness | <0.0001 | ||||||||||
Indolent NHL | 355 (25%) | Ann Arbor Stage | 0.056 | Ann Arbor Stage | 0.002 | ||||||
Aggressive NHL | 532 (45%) | I-II | 72 (26%) | I-II | 285 (30%) | ||||||
CLL/SLL | 275 (27%) | III-IV | 54 (43%) | III-IV | 575 (41%) | ||||||
Subtype | <0.0001 | ||||||||||
FL | 241 (26%) | ||||||||||
DLBCL | 295 (46%) | ||||||||||
MCL | 57 (44%) | ||||||||||
Post FL | 128 (22%) | ||||||||||
T-Cell | 68 (43%) | ||||||||||
Other NHL | 78 (62%) |
CLL/SLL: Chronic lymphocytic leukemia/Small lymphocytic lymphoma; HL: Hodgkin lymphoma; NHL: non-Hodgkin lymphoma; IPS: International Prognostic Score; IPI: International Prognostic Index; FL: Follicular lymphoma; DLBCL: Diffuse large B-cell lymphoma; MCL: Mantle cell lymphoma; T-Cell: T-cell lymphoma